These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9228909)

  • 21. Interchangeability of levothyroxine preparations.
    DeGroot LJ
    Am J Med; 1996 Feb; 100(2):244-5; author reply 246-7. PubMed ID: 8629664
    [No Abstract]   [Full Text] [Related]  

  • 22. Levothyroxine and FDA bioequivalence ratings.
    Fox GN
    J Fam Pract; 2005 Feb; 54(2):179. PubMed ID: 15689298
    [No Abstract]   [Full Text] [Related]  

  • 23. Interchangeability of levothyroxine preparations.
    Bootman JL
    Am J Med; 1996 Feb; 100(2):247-8; author reply 248-9. PubMed ID: 8629667
    [No Abstract]   [Full Text] [Related]  

  • 24. Current methodology to assess bioequivalence of levothyroxine sodium products is inadequate.
    Blakesley VA
    AAPS J; 2005 Mar; 7(1):E42-6. PubMed ID: 16146348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary hypothyroidism.
    Carnell NE; Wilber JF
    Curr Ther Endocrinol Metab; 1994; 5():82-5. PubMed ID: 7704807
    [No Abstract]   [Full Text] [Related]  

  • 26. Multiple level C in vitro/in vivo correlation of dissolution profiles of two L-thyroxine tablets with pharmacokinetics data obtained from patients treated for hypothyroidism.
    Volpato NM; Silva RL; Brito AP; Gonçalves JC; Vaisman M; Noël F
    Eur J Pharm Sci; 2004 Apr; 21(5):655-60. PubMed ID: 15066666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is combined therapy with levothyroxine and liothyronine effective in patients with primary hypothyroidism?
    Pinchera A; Santini F
    Nat Clin Pract Endocrinol Metab; 2005 Nov; 1(1):18-9. PubMed ID: 16929361
    [No Abstract]   [Full Text] [Related]  

  • 28. Raloxifene causing malabsorption of levothyroxine.
    Siraj ES; Gupta MK; Reddy SS
    Arch Intern Med; 2003 Jun; 163(11):1367-70. PubMed ID: 12796075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioequivalence of thyroid preparations: the final word?
    Gibaldi M
    AAPS J; 2005; 7(1):E59-60. PubMed ID: 16493834
    [No Abstract]   [Full Text] [Related]  

  • 30. In vivo comparison of levothyroxine preparations.
    Ramos-Gabatin A; Jacobson JM; Young RL
    JAMA; 1982 Jan; 247(2):203-5. PubMed ID: 7053460
    [No Abstract]   [Full Text] [Related]  

  • 31. [Preventable problems in thyroid hormone substitution therapy. The risks of brand change are unpredictable].
    MMW Fortschr Med; 2010 Jun; 152(22):46-7. PubMed ID: 20590034
    [No Abstract]   [Full Text] [Related]  

  • 32. Bioequivalence of two commercially available levothyroxine-Na preparations in athyreotic patients.
    Gottwald R; Lorkowski G; Petersen G; Schnitzler M; Lücker PW
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):645-50. PubMed ID: 7746026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Levothyroxine and generics: current reflections].
    Orgiazzi J; Wémeau JL
    Rev Prat; 2014 Mar; 64(3):304-6. PubMed ID: 24851355
    [No Abstract]   [Full Text] [Related]  

  • 34. Ingestion of large amounts of papaya fruit and impaired effectiveness of levothyroxine therapy.
    Deiana L; Marini S; Mariotti S
    Endocr Pract; 2012; 18(1):98-100. PubMed ID: 21856591
    [No Abstract]   [Full Text] [Related]  

  • 35. Absorption kinetics of levothyroxine is not altered by proton-pump inhibitor therapy.
    Dietrich JW; Gieselbrecht K; Holl RW; Boehm BO
    Horm Metab Res; 2006 Jan; 38(1):57-9. PubMed ID: 16477543
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bioavailability of a thyroxine preparation and its use in primary hypothyroidism].
    Michaud P; Tellez R; Rodríguez J; Correa L; Risopatrón V
    Rev Med Chil; 1986 Mar; 114(3):206-10. PubMed ID: 3809793
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prescribing levothyroxine. Preparation hopping risks accurate regulation].
    MMW Fortschr Med; 2009 Mar; 151(12):37. PubMed ID: 19475856
    [No Abstract]   [Full Text] [Related]  

  • 38. Does substitution of T4 with T3 plus T4 for T4 replacement improve depressive symptoms in patients with hypothyroidism?
    Joffe RT; Sawka AM; Marriott MJ; MacQueen GM; Gernstein HC
    Ann N Y Acad Sci; 2004 Dec; 1032():287-8. PubMed ID: 15677430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noncompliance with medical treatment: pseudomalabsorption of levothyroxine.
    Eledrisi MS; Szymajda A; Alshanti M; Urban RJ
    South Med J; 2001 Aug; 94(8):833-6. PubMed ID: 11549198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hypothyroidism--therapy].
    Schumm-Draeger PM; Müller OA
    Dtsch Med Wochenschr; 2004 Jul; 129(28-29):1574-6. PubMed ID: 15243907
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.